Across neuroscience, a growing focus is emerging around not just protecting the brain, but actively restoring and reshaping it after injury and disease. Recent studies highlight how targeted interventions at the cellular and molecular level can influence recovery in very different conditions, from spinal cord injury to stroke to Alzheimer’s disease. Together, they reflect a shift toward precision strategies that either rebuild damaged neural circuits, prevent cell death, or alter the underlying biology driving degeneration.

One study demonstrates how spermatogonial stem cells can be converted into functional spinal neurons that survive, integrate, and improve motor recovery after spinal cord injury. Another shows that delivering mitochondrial circular RNA through extracellular vesicles can protect brain tissue after stroke by blocking ferroptosis, reducing damage and improving outcomes. A third explores how a selective G9a inhibitor can modify disease progression in Alzheimer’s by reducing toxic protein buildup and improving cognitive function. Taken together, these findings point toward a future where regeneration, protection, and epigenetic control are combined to meaningfully change the trajectory of central nervous system disorders.